scispace - formally typeset
J

Jose M. Ordovas

Researcher at Tufts University

Publications -  1063
Citations -  79038

Jose M. Ordovas is an academic researcher from Tufts University. The author has contributed to research in topics: Population & Cholesterol. The author has an hindex of 123, co-authored 1024 publications receiving 70978 citations. Previous affiliations of Jose M. Ordovas include University of Seville & IMDEA.

Papers
More filters
Journal ArticleDOI

Biological, clinical and population relevance of 95 loci for blood lipids

Tanya M. Teslovich, +218 more
- 05 Aug 2010 - 
TL;DR: The results identify several novel loci associated with plasma lipids that are also associated with CAD and provide the foundation to develop a broader biological understanding of lipoprotein metabolism and to identify new therapeutic opportunities for the prevention of CAD.
Journal ArticleDOI

Discovery and refinement of loci associated with lipid levels

Cristen J. Willer, +319 more
- 06 Oct 2013 - 
TL;DR: It is found that loci associated with blood lipid levels are often associated with cardiovascular and metabolic traits, including coronary artery disease, type 2 diabetes, blood pressure, waist-hip ratio and body mass index.
Journal ArticleDOI

Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study

Benjamin F. Voight, +140 more
TL;DR: In this paper, a Mendelian randomisation analysis was performed to compare the effect of HDL cholesterol, LDL cholesterol, and genetic score on risk of myocardial infarction.
Journal ArticleDOI

Mixed linear model approach adapted for genome-wide association studies.

TL;DR: A compression approach is reported, called 'compressed MLM', that decreases the effective sample size of such datasets by clustering individuals into groups and a complementary approach, 'population parameters previously determined' (P3D), that eliminates the need to re-compute variance components.

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

Benjamin F. Voight, +125 more
TL;DR: Mendelian randomisation analyses challenge the concept that raising of plasma HDL cholesterol will uniformly translate into reductions in risk of myocardial infarction.